Context and Objective: Although psychotropics are one of the classes of medications most prescribed in nursing homes for the elderly, studies examining prescribing patterns are limited in both number and scope. The present study was undertaken to investigate factors associated with general psychotropic use in a nursing home in Brazil. Design and Setting: Retrospective observational study at the Nursing Home for the Elderly, Institute of Biosciences, Universidade Estadual Paulista. Methods: Information on prescriptions was retrieved from the medical records of 108 elderly residents in a nursing home. Sixty-five of these patients, with mean age 74.5 years (± standard deviation 9.4 years), who were taking medications on a regular basis, comprised the sample. The effects of demographic and clinical variables on the psychotropic prescription pattern were examined. Results: Females were more likely to receive psychotropics (p = 0.038). Individuals on medicines for cardiovascular diseases received psychotropics less frequently (p = 0.001). The number of prescribed psychotropics correlated negatively with both age (p = 0.009) and number of non-psychotropic drugs (p = 0.009). Conclusions: Although preliminary, the present results indicated that cardiovascular disease was the clinical variable that most influenced psychotropic prescription. Physicians' overconcern regarding drug interactions might at least partially explain this result. Further investigations involving larger sample sizes from different regions are warranted to confirm these findings. © 2007 Associação Paulista de Medicina.1245253256Snowdon, J., Vaughan, R., Miller, R., Burgess, E.E., Tremlett, P., Psychotropic drug use in Sydney nursing homes (1995) Med J Aust, 163 (2), pp. 70-72Katona, C.L., Psychotropics and drug interactions in the elderly patient (2001) Int J Geriatr Psychiatry, 16 (SUPPL. 1), pp. S86-S90Buck, J.A., Psychotropic drug practice in nursing homes (1988) J Am Geriatr Soc, 36 (5), pp. 409-418Ruby, C.M., Kennedy, D.H., Psychopharmacologic medication use in nursing-home care: Indicators for surveyor assessment of the performance of drug-regimen reviews, recommendations for monitoring, and nonpharmacologic alternatives (2001) Clin Family Practice, 3, pp. 577-598Sorensen, L., Foldspang, A., Gulmann, N.C., Munk-Jorgensen, P., Determinants for the use of psychotropics among nursing home residents (2001) Int J Geriatr Psychiatry, 16 (2), pp. 147-154Robinson, M.J., Levenson, J.L., The use of psychotropics in the medically ill (2000) Curr Psychiatry Rep, 2 (3), pp. 247-255Mort, J.R., Aparasu, R.R., Prescribing of psychotropics in the elderly: Why is it so often inappropriate? (2002) CNS Drugs, 16 (2), pp. 99-109Dealberto, M.J., Seeman, T., McAvay, G.J., Berkman, L., Factors related to current and subsequent psychotropic drug use in an elderly cohort (1997) J Clin Epidemiol, 50 (3), pp. 357-364Fichter, M.M., Witzke, W., Leibl, K., Hippius, H., Psychotropic drug use in a representative community sample: The Upper Bavarian study (1989) Acta Psychiatr Scand, 80 (1), pp. 68-77Nirodi, P., Mitchell, A.J., The quality of psychotropic drug prescribing in patients in psychiatric units for the elderly (2002) Aging Ment Health, 6 (2), pp. 191-196Ancill, R.J., Embury, G.D., MacEwan, G.W., Kennedy, J.S., The use and misuse of psychotropic prescribing for elderly psychiatric patients (1988) Can J Psychiatry, 33 (7), pp. 585-589Smid, J., Nitrini, R., Bahia, V.S., Caramelli, P., Clinical characterization of vascular dementia: Retrospective evaluation of an outpatient sample (2001) Arq Neuropsiquiatr, 59 (2 B), pp. 390-393Reilly, J.G., Ayis, S.A., Ferrier, I.N., Jones, S.J., Thomas, S.H., QTc-interval abnormalities and psychotropic drug therapy in psychiatric patients (2000) Lancet, 355 (9209), pp. 1048-1052Hansen, S., Mental health issues associated with cardiovascular disease in women (2003) Psychiatr Clin North Am, 26 (3), pp. 693-712Ryan, J.M., Kidder, S.W., Daiello, L.A., Tariot, P.N., Psychopharmacologic interventions in nursing homes: What do we know and where should we go? (2002) Psychiatr Serv, 53 (11), pp. 1407-1413Linden, M., Lecrubier, Y., Bellantuono, C., Benkert, O., Kisely, S., Simon, G., The prescribing of psychotropic drugs by primary care physicians: An international collaborative study (1999) J Clin Psychopharmacol, 19 (2), pp. 132-140Linjakumpu, T., Hartikainen, S., Klaukka, T., Koponen, H., Kivela, S.L., Isoaho, R., Psychotropics among the home-dwelling elderly - Increasing trends (2002) Int J Geriatr Psychiatry, 17 (9), pp. 874-883Aparasu, R.R., Mort, J.R., Brandt, H., Psychotropic prescription use by community-dwelling elderly in the United States (2003) J Am Geriatr Soc, 51 (5), pp. 671-677Hohmann, A.A., Gender bias in psychotropic drug prescribing in primary care (1989) Med Care, 27 (5), pp. 478-490Gleason, P.P., Schulz, R., Smith, N.L., Correlates and prevalence of benzodiazepine use in community-dwelling elderly (1998) J Gen Intern Med, 13 (4), pp. 243-250Holmquist, I.B., Svensson, B., Hoglund, P., Psychotropic drugs in nursing- and old-age homes: Relationships between needs of care and mental health status (2003) Eur J Clin Pharmacol, 59 (8-9), pp. 669-676Robins, L.N., Helzer, J.E., Weissman, M.M., Lifetime prevalence of specific psychiatric disorders in three sites (1984) Arch Gen Psychiatry, 41 (10), pp. 949-958van der Waals, F.W., Mohrs, J., Foets, M., Sex differences among recipients of benzodiazepines in Dutch general practice (1993) BMJ, 307 (6900), pp. 363-366Mellinger, G.D., Balter, M.B., Uhlenhuth, E.H., Prevalence and correlates of the long-term regular use of anxiolytics (1984) JAMA, 251 (3), pp. 375-379Verbrugge, L.M., Gender and health: An update on hypotheses and evidence (1985) J Health Soc Behav, 26 (3), pp. 156-182